• 2016 szívünk napja 01
  • 2016 szívünk napja 02
  • 2016 szívünk napja 03
  • 2016 szívünk napja 06
  • 2016 szívünk napja 04
  • 2016 szívünk napja 05
  • 2016 szívünk napja 10
  • 2016 szívünk napja 07
  • 2016 szívünk napja 09
  • 2016 szívünk napja 08
  • 2016 szívünk napja 14
  • 2016 szívünk napja 11
  • 2016 szívünk napja 12
  • 2016 szívünk napja 13
  • 2016 szívünk napja 17
  • 2016 szívünk napja 15
  • 2016 szívünk napja 16
Information, patient follow-up in cardiology is a key issue in particular - the SZÍVSN national patient association has launched a coordinating tender
During the last 10 years the SZIVSN (helping you!) Heartily National Association has been actively teaching, forming, supporting and representing heart disease and inherited high cholesterol disease (familial hyperesterolyemia FH).
FH EUROPE also included a poem by Dr. Ákos Gesztes (page 18)
I would like to invite you to an online interactive presentation starting at 5 pm on Friday, June 18, 2021!
December 2020, we held our 250th SZÍVSN event, this year for patients with heart disease and those interested in heart function, disease development and rehabilitation, so far in front of 6000 people in the lecture hall of the Városmajor Cardiovascular Clinic. The main topics are: infarction and its treatment, pacemaker and ICD lifestyle, lifestyle of patients with arrhythmias, lifestyle of patients taking anticoagulant drugs, informing patients with genetically high cholesterol, health awareness nowadays.
Fighting cardiovascular disease – a blueprint for EU action

In October 2018, the FH Foundation, at its annual Global Summit honored Roger Williams MD to commemorate the twentieth anniversary of publication of the World Health Organization (WHO) Consultation on familial hypercholesterolemia (FH), the most common genetic disorder causing premature atherosclerotic cardiovascular disease, and underscore continued gaps in identification and care. (1) FH, with a prevalence of about 1:220-250 worldwide, causes lifelong elevated levels of low-density lipoprotein cholesterol (LDL-c).

We would like to invite you to participate in the Patient Organisation Advisory Board Meeting concerning Heart Failure (HF) organised by Boehringer Ingelheim RCV GmbH & Co KG, which will be held online due to the current COVID-19 situation.

AIPM has launched a pioneering international initiative which aims to enhance cooperation with patients and patient organizations in the Central and Eastern European region.